We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Celgene Corporation | NASDAQ:CELG | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 108.24 | 109.30 | 109.37 | 0 | 01:00:00 |
FORM 3
|
Washington, D.C. 20549 |
OMB APPROVAL
OMB Number: 3235-0104 Estimated average burden hours per response... 0.5 |
|
|
|
1. Name and Address of Reporting Person * Biller Jonathan |
2. Date of Event Requiring Statement (MM/DD/YYYY)
|
3. Issuer Name and Ticker or Trading Symbol CELGENE CORP /DE/ [CELG] |
|
4. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director
_____ 10% Owner
___ X ___ Officer (give title below) _____ Other (specify below) EVP and General Counsel / |
|
|
5. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Beneficially Owned |
|||
1.Title of Security
(Instr. 4) |
2. Amount of Securities Beneficially Owned
(Instr. 4) |
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5) |
4. Nature of Indirect Beneficial Ownership
(Instr. 5) |
Common Stock | 2146 | D |
|
Common stock | 282 | I | 401(k) |
Common Stock | 400 | I | Spouse (1) |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||
1. Title of Derivate Security
(Instr. 4) |
2. Date Exercisable and Expiration Date
(MM/DD/YYYY) |
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4) |
4. Conversion or Exercise Price of Derivative Security |
5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5) |
6. Nature of Indirect Beneficial Ownership
(Instr. 5) |
||
Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
Stock Option (right to buy) | (2) (3) | 10/28/2023 | Common Stock | 1564 | $78.12 | D |
|
Stock Option (right to buy) | (2) (3) | 12/2/2023 | Common Stock | 726 | $81.56 | D |
|
Stock Option (right to buy) | (2) (3) | 2/3/2024 | Common Stock | 1564 | $74.30 | D |
|
Stock Option (right to buy) | (3) (4) | 7/28/2024 | Common Stock | 1563 | $87.64 | D |
|
Stock Option (right to buy) | (3) (5) | 10/27/2024 | Common Stock | 1563 | $103.10 | D |
|
Stock Option (right to buy) | (3) (6) | 12/19/2024 | Common Stock | 3500 | $117.18 | D |
|
Stock Option (right to buy) | (3) (7) | 2/2/2025 | Common Stock | 3125 | $118.57 | D |
|
Stock Option (right to buy) | (3) (8) | 5/4/2025 | Common Stock | 3125 | $109.90 | D |
|
Stock Option (right to buy) | (3) (9) | 7/27/2025 | Common Stock | 3125 | $132.56 | D |
|
Stock Option (right to buy) | (3) (10) | 11/9/2025 | Common Stock | 3125 | $114.08 | D |
|
Stock Option (right to buy) | (3) (11) | 2/1/2026 | Common Stock | 2344 | $100.80 | D |
|
Stock Option (right to buy) | (3) (12) | 5/2/2026 | Common Stock | 2344 | $104.97 | D |
|
Stock Option (right to buy) | (3) (13) | 8/1/2026 | Common Stock | 3125 | $114.69 | D |
|
Stock Option (right to buy) | (3) (14) | 10/31/2026 | Common Stock | 6250 | $102.18 | D |
|
Stock Option (right to buy) | (3) (15) | 1/30/2027 | Common Stock | 6250 | $113.18 | D |
|
Stock Option (right to buy) | (3) (16) | 5/1/2027 | Common Stock | 3125 | $124.06 | D |
|
Stock Option (right to buy) | (3) (17) | 7/31/2027 | Common Stock | 3125 | $135.41 | D |
|
Stock Option (right to buy) | (3) (18) | 10/30/2027 | Common Stock | 3438 | $100.97 | D |
|
Stock Option (right to buy) | (3) (19) | 1/29/2028 | Common Stock | 3437 | $103.26 | D |
|
Stock Option (right to buy) | (3) (20) | 5/8/2028 | Common Stock | 4688 | $83.13 | D |
|
Restricted Stock Unit | (21) | (21) | Common Stock | 1900 | (22) (23) | D |
|
Restricted Stock Unit | (24) | (24) | Common Stock | 1563 | (22) (23) | D |
|
Restricted Stock Unit | (25) | (25) | Common Stock | 3125 | (22) (23) | D |
|
Restricted Stock Unit | (26) | (26) | Common Stock | 1563 | (22) (23) | D |
|
Restricted Stock Unit | (27) | (27) | Common Stock | 6719 | (22) (23) | D |
|
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
Biller Jonathan
C/O CELGENE CORPORATION 86 MORRIS AVENUE SUMMIT, NJ 07901 |
|
|
EVP and General Counsel |
|
Signatures
|
||
/s/ Jonathan Biller | 7/12/2018 | |
** Signature of Reporting Person | Date |
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 5(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Celgene Chart |
1 Month Celgene Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions